Lebwohl, Mark G, Jeffrey Sugarman, David M Pariser, Jerry Bagel, Cynthia Trickett, Abby Jacobson, and Robert Israel. 2020. “Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study”. SKIN The Journal of Cutaneous Medicine 4 (5):s38. https://doi.org/10.25251/skin.4.supp.38.